Diseases · Entity Annotation Prototype (beta)

3articles mentioning diseases

3disease mentions

1distinct diseases extracted

0%of mentions human-reviewed

Active filtersEntity: extensive-stage small-cell lung cancer ×

extensive-stage small-cell lung cancer

This disease is selected. Its supporting articles are shown below.

extensive-stage small-cell lung cancer3

Articles mentioning extensive-stage small-cell lung cancer

3 articles · page 1 of 1

2SPD-021 Indirect comparison of first-line treatment with tislelizumab, atezolizumab or durvalumab for patients with extensive-stage small-cell lung cancer

ejhpharm · abstract · 2026-03-18 · 1 matching annotations

80.1%

ES-SCLC extensive-stage small-cell lung cancer Tislelizumab durvalumab atezolizumab

…d consistent placebo outcomes, they may be considered CETAs for ES-SCLC first-line treatment, despite potential OS bias from subsequent…

4CPS-229 Immunotherapy time-of-day infusion, what about small-cell lung cancer?

ejhpharm · abstract · 2026-03-18 · 1 matching annotations

78.9%

ES-SCLC extensive-stage small-cell lung cancer solid tumours atezolizumab tertiary hospital anticancer immunotherapy

…izumab infusions (early vs late) is associated with efficacy in ES-SCLC. The primary outcome was overall survival (OS). Secondary outco…

409 Real-world outcomes for patients with extensive-stage small cell lung cancer treated with chemo-immunotherapy in the veterans affair system

jitc · abstract · 2025-11-04 · 1 matching annotations

96.2%

extensive-stage small cell lung cancer extensive-stage small-cell lung cancer ES-SCLC durvalumab atezolizumab platinum-etoposide tremelimumab immunotherapy

…uszko R, Sugawara S, et al. Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the phase III IMpower133 study and…